Pfizer Analysis Makes Case For COVID Vaccine Booster

1

Pfizer says data support its request for Food and Drug Administration approval of a third dose of COVID vaccine about six months after the second dose in people 16 years and older.

(Image credit: Bloomberg/Bloomberg via Getty Images)

Loading...